
Blog
Bispecific LV20.19 CAR T Cells Induce 92% CR Rate in Relapsed/Refractory Mantle Cell Lymphoma
Mantle cell lymphoma (MCL) is an aggressive B-cell malignancy that

Mantle cell lymphoma (MCL) is an aggressive B-cell malignancy that

Many ovarian tumors contain mesothelin. Researchers wanted to test three

CAR T cells have shown some success in the clinic

Lymphomas can begin in the brain or spinal cord, or

T-cell transfer therapies have not yet been successfully applied to

Surgery can be curative when a solid tumor cancer has

The immune system can induce metabolic adaptations in tumor cells

Until recently, most CAR-T therapies were made from the patient’s
Cookies
We use audience measurement cookies (Google Analytics) to improve this website. They are only set with your consent. You can change your mind at any time via “Cookie settings” at the bottom of the page. Privacy & Cookies Policy